[Urinary incontinence--treatment].
Hader
C
C
Zentrum für Innere Medizin, Kliniken St. Antonius, Wuppertal. claushader@hotmail.com
Welz-Barth
A
A
Keller
T
T
D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001521:Behavior Therapy; D001559:Benzhydryl Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001561:Benzilates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001676:Biofeedback, Psychology; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000075202:Contraindications; D003408:Cresols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004599:Electric Stimulation Therapy; D005260:Female; D006801:Humans; D007099:Imipramine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008333:Mandelic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009662:Nortropanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010276:Parasympatholytics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010665:Phenylpropanolamine; D026741:Physical Therapy Modalities; D012076:Renal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000068737:Tolterodine Tartrate; D014549:Urinary Incontinence / Q000145:classification / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D014550:Urinary Incontinence, Stress / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy
D018759:Adrenergic Uptake Inhibitors; D001559:Benzhydryl Compounds; D001561:Benzilates; D018680:Cholinergic Antagonists; D003408:Cresols; D008333:Mandelic Acids; D018727:Muscarinic Antagonists; D009662:Nortropanes; D010276:Parasympatholytics; D012076:Renal Agents; C003330:trospium chloride; D010665:Phenylpropanolamine; C015586:propiverine; D000068737:Tolterodine Tartrate; D003894:Deamino Arginine Vasopressin; C005419:oxybutynin; D007099:Imipramine